2.3400
-0.0300
(-1.27%)
At close: January 30 at 4:00:01 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-81,548.0000
-53,549.0000
-46,380.0000
-34,109.0000
-26,770.0000
Investing Cash Flow
36,301.0000
-22,451.0000
-27,217.0000
5,999.0000
-7,981.0000
Financing Cash Flow
100,354.0000
187,631.0000
32,982.0000
48,903.0000
-24.0000
End Cash Position
170,608.0000
193,238.0000
81,607.0000
122,222.0000
101,429.0000
Capital Expenditure
-2,020.0000
-687.0000
-2,453.0000
-1,166.0000
-635.0000
Issuance of Capital Stock
97,485.0000
185,202.0000
32,855.0000
48,253.0000
--
Repurchase of Capital Stock
--
--
--
--
-192.0000
Free Cash Flow
-83,568.0000
-54,236.0000
-48,833.0000
-35,275.0000
-27,405.0000
12/31/2020 - 10/25/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
KYTX Kyverna Therapeutics, Inc.
3.3100
+2.16%
NKTX Nkarta, Inc.
2.3600
+5.36%
VTYX Ventyx Biosciences, Inc.
2.0500
+5.67%
BDTX Black Diamond Therapeutics, Inc.
2.5200
+3.28%
STOK Stoke Therapeutics, Inc.
10.99
+4.57%
ZNTL Zentalis Pharmaceuticals, Inc.
1.6600
-12.17%
FDMT 4D Molecular Therapeutics, Inc.
5.60
+12.00%
GOSS Gossamer Bio, Inc.
0.9637
+4.91%
APLT Applied Therapeutics, Inc.
0.5931
+8.89%
PASG Passage Bio, Inc.
0.5848
+1.46%